Literature DB >> 2228350

Brief group psychotherapy in relapse prevention for alcohol dependent patients.

C Sandahl1, S Rönnberg.   

Abstract

The effects of brief group psychotherapy in relapse prevention were tested. The groups focused on the clients' capacity to formulate their own treatment goals, including controlled drinking, programmed relapse, and total abstinence. Twelve months after completion of the eight-week outpatient group treatment, thirty-five clients were followed up. There appeared to be no harmful effects as a result of the treatment. Nobody in the follow-up group had a deteriorated drinking pattern as compared to pretreatment data. The follow-up results were significantly better than before treatment and also than in a comparison group of alcohol dependent patients. It seemed as if those patients who could benefit from the treatment had a shorter duration of abuse and had a later onset of uncontrolled drinking compared to those who continued with a negative drinking pattern and the dropouts. The clients assigned the positive treatment effects to course leaders' encouragement of personal decision making, increased awareness of risk situations, and improved coping skills. The group situation in itself seemed to be of special importance for this result. The degree of structure implemented by course leaders allowed a free and respectful openness to develop between group members.

Entities:  

Mesh:

Year:  1990        PMID: 2228350     DOI: 10.1080/00207284.1990.11490622

Source DB:  PubMed          Journal:  Int J Group Psychother        ISSN: 0020-7284


  2 in total

1.  Motivational Interviewing and Relapse Prevention for DWI: A Pilot Study.

Authors:  L A R Stein; Rebecca Lebeau-Craven
Journal:  J Drug Issues       Date:  2002

2.  A 12-session relapse prevention program vs psychoeducation in the treatment of Japanese alcoholic patients: A randomized controlled trial.

Authors:  Takayuki Harada; Yuzo Aikawa; Mihoko Takahama; Yosuke Yumoto; Mitsuru Umeno; Yukako Hasegawa; Shigeo Ohsawa; Nozomu Asukai
Journal:  Neuropsychopharmacol Rep       Date:  2022-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.